Wave Pharmaceuticals Limited, a active public limited company, was established on 08 August 1997 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1997PLC088998. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.95 Cr.
It upholds a compliant status. Its leadership includes Nikhil Gupta (Director), Sanjay Gupta (Director), Sarita Gupta (Director). Past directors included Vijay Kumar Matta, Nikhil Gupta, Neelu Matta. It holds no open charges and ₹5.07 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-6, Oberoi Appartments, 2 Sham Nath Marg, Civil Lines, Delhi, Delhi, 110054.
U24231DL1997PLC088998
088998
08 August 1997
₹5.00 Cr
₹4.95 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Wave Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Gupta | Director | 28 Jan 2017 | Current |
| Sanjay Gupta | Director | 28 Jan 2017 | Current |
| Sarita Gupta | Director | 10 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Feb 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 01 Feb 2017 | Past |
| Pramod Abcsdd | Director | 10 Feb 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 01 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wave Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.7% increase. The company also saw a slight decrease in profitability, with a 2.13% decrease in profit. The company's net worth moved up by a moderate rise of 6.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Wave Pharmaceuticals had a promoter holding of 95.70% and a public holding of 4.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,065,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2003 | Canara Bank | ₹2.50 M | Satisfied |
| 12 Dec 2001 | Punjab National Bank | ₹2.57 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Wave Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Wave Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wave Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Wave Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Wave Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Sarita Gupta was appointed as a Director was appointed as a Director on 10 Feb 2018 & has been associated with this company since 7 years 10 months . was documented.
A charge registered on 07 Mar 2003 via Charge ID 90037931 with Canara Bank was fully satisfied on 30 Aug 2017. was recorded as a recent event.
Progress on A charge registered on 12 Dec 2001 via Charge ID 90036942 with Punjab National Bank was fully satisfied on 29 Aug 2017. was documented.
Progress on Nikhil Gupta was appointed as a Director was appointed as a Director on 28 Jan 2017 & has been associated with this company since 8 years 10 months . was documented.
The CIN of Wave Pharmaceuticals Limited is U24231DL1997PLC088998.
Wave Pharmaceuticals Limited is headquartered at B-6, Oberoi Appartments, 2 Sham Nath Marg, Civil Lines, Delhi, Delhi, 110054.
Wave Pharmaceuticals Limited was incorporated on 08 August 1997.
The current directors of Wave Pharmaceuticals Limited are
The primary industry of Wave Pharmaceuticals Limited is Manufacturing.
Wave Pharmaceuticals Limited is unlisted.
The authorized capital of Wave Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹4.95 Cr.
The compliance status of Wave Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX